healthmedicinet

Daily News and Tips

MENU

June 1, 2015

Esperance announces positive results from EP-100 Phase II trial in paclitaxel-resistant ovarian cancer

Esperance Pharmaceuticals, Inc.

May 2024
M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

« Apr

Search

Copyright © 2024 | healthmedicinet